K-V Pharmaceutical Co - FORM 10-K - EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - March 25, 2010

Attached files

file filename
10-K - FORM 10-K - K-V Pharmaceutical Cod10k.htm
EX-21 - LIST OF SUBSIDIARIES - K-V Pharmaceutical Codex21.htm
EX-3.1 - CERTIFICATE OF INCORPORATION - K-V Pharmaceutical Codex31.htm
EX-23.1 - CONSENT OF KPMG LLP - K-V Pharmaceutical Codex231.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) - K-V Pharmaceutical Codex312.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - K-V Pharmaceutical Codex322.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) - K-V Pharmaceutical Codex311.htm
EX-10.41 - AGREEMENT AND RELEASE - K-V Pharmaceutical Codex1041.htm
EX-10.30 - SEPARATION AGREEMENT AND GENERAL RELEASE - K-V Pharmaceutical Codex1030.htm
EX-10.13 - FORM OF INCENTIVE STOCK OPTION AGREEMENT - K-V Pharmaceutical Codex1013.htm
EX-10.42 - FOURTH AMENDMENT TO EMPLOYMENT AND CONFIDENTIAL INFORMATION AGREEMENT - K-V Pharmaceutical Codex1042.htm
EX-10.31 - CONSULTING AND CONFIDENTIALITY AGREEMENT - K-V Pharmaceutical Codex1031.htm
EX-10.48 - AMENDMENT, DATED JANUARY 8, 2010, TO THE ASSET PURCHASE AGREEMENT - K-V Pharmaceutical Codex1048.htm
EX-10.38 - EMPLOYMENT AGREEMENT - K-V Pharmaceutical Codex1038.htm
EX-10.14 - FORM OF NONQUALIFIED STOCK OPTION AGREEMENT FOR GRANTS TO EMPLOYEES - K-V Pharmaceutical Codex1014.htm
EX-10.15 - FORM OF NONQUALIFIED STOCK OPTION AGREEMENT FOR GRANTS TO DIRECTORS - K-V Pharmaceutical Codex1015.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of K-V Pharmaceutical Company (the “Company”) on Form 10-K for the fiscal year ended March 31, 2009, as filed with the Securities and Exchange Commission (the “Report”), I, David A. Van Vliet, Interim President and Interim Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 25, 2010       /s/ David A. Van Vliet
     

David A. Van Vliet

Interim President and Interim Chief Executive Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished to the Securities and Exchange Commission as our exhibit to the Form 10-K and shall not be deemed to be considered filed as part of the Form 10-K.

K-V Pharmaceutical Co Reports

Also read